In a co-branded Scientific American-World Economic Forum session at the Annual Meeting of New Champions, or “Summer Davos,” in Tianjin, China, Editor in Chief Mariette DiChristina leads a discussion with Aura Biosciences CEO Elisabeth de los Pinos Pont, Illumina Executive Chairman Jay Flatley and BGI President Wang Jian on how business and government can bridge the gap between availability and access as genomic technologies move from lab to clinic.
Mariette DiChristina, Steering Group chair, is dean and professor of the practice in journalism at the Boston University College of Communication. She was formerly editor in chief of Scientific American and executive vice president, Magazines, for Springer Nature. Follow Mariette DiChristina on Twitter Credit: Nick Higgins
Rights & Permissions
